Voluson S6, Voluson S8, Voluson S8t, Voluson S10, Voluson S10 Expert
GE Healthcare • Radiology • 01/13/2022
Device Purpose
The Voluson S Series (S6, S8, S8t, S10, S10 Expert) are versatile diagnostic ultrasound systems designed for comprehensive imaging, measurement, and analysis across diverse clinical applications, notably in general radiology and OB/GYN, utilizing a mobile console and a variety of transducers. These systems employ established ultrasound technology with multiple imaging modes, including 3D/4D, Doppler, and Elastography, and incorporate new software features like SonoCNS and expanded probe compatibility to enhance diagnostic capabilities.
Summary
The Voluson S Series, encompassing models S6, S8, S8t, S10, and S10 Expert, are general-purpose diagnostic ultrasound systems designed for use by qualified healthcare professionals. These systems facilitate ultrasound imaging, measurement, display, and analysis of the human body and fluid across a wide range of clinical applications, including fetal/obstetrics, abdominal (renal, GYN/pelvic), pediatric, small organs (breast, testes, thyroid), cephalic (neonatal and adult), cardiac (adult and pediatric), peripheral vascular, musculo-skeletal, transrectal, and transvaginal procedures. The systems feature a mobile console, various transducers (linear, curved linear, matrix phased array), and capabilities for real-time 3D/4D acquisition, with DICOM and networking support. Model variations primarily involve the presence of a touch panel user interface on the S10 Expert, S10, and S8t models, and the S10 Expert offering the most comprehensive set of features and probe compatibility. The Voluson S Series operates using established ultrasound principles, supporting numerous imaging modes such as B-mode, M-mode, Pulsed Wave and Continuous Wave Doppler, Color Doppler, Power Doppler, Tissue Doppler, HD-Flow, Harmonic Imaging, 3D/4D imaging, Elastography, and B-Flow. Key updates include the migration of the IC9B-RS probe and software features like SonoCNS, Uterine Trace, and Sonobiometry Brain from the Voluson SWIFT system. The C2-9-RS probe's availability has been expanded across more models in the series. Further enhancements comprise improvements to IDEA Assessment, IOTA ADNEX, IETA Tool, Sono FHR, SonoAVCantral2.0, along with OS and security updates, and refreshed connectivity. Non-clinical testing confirmed adherence to safety and performance standards, including acoustic output, biocompatibility, and electrical safety.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How do the migrated software features (SonoCNS, Uterine Trace, Sonobiometry Brain) quantitatively improve diagnostic efficiency or accuracy in obstetric and gynecological assessments compared to systems without them?; What specific image quality enhancements or clinical benefits does the IC9B-RS transducer bring to the Voluson S Series, particularly for its specialized applications like transvaginal imaging?; Can the expansion of the C2-9-RS probe to all Voluson S models, including the S6 and S8, offer comparable diagnostic performance for general abdominal and obstetric imaging as seen on higher-end models?; Are there comparative studies demonstrating the impact of the 'minor improvements' like IDEA Assessment, IOTA ADNEX, and IETA Tool on specific diagnostic workflows or inter-observer variability?; How does the system architecture of the different Voluson S models (S6, S8, S8t, S10, S10 Expert) accommodate the varying feature sets and probe compatibilities, particularly regarding processing power for advanced modes like 3D/4D and Elastography?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of SaaSBOM, VDR/VEX detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, ML-BOM, HBOM, CBOM, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly